Tiedemann Advisors’s Idexx Laboratories IDXX Stock Holding History

Tiedemann Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,306	Closed	-$2.09M	–	326
2021 Q2	$2.09M	Buy	+3,306	New	+$1.83M	0.08%	103
2020 Q2	–	Sell	-855	Closed	-$207K	–	304
2020 Q1	$207K	Sell	855 -10	-1%	-$2.61K	0.01%	273
2019 Q4	$226K	Sell	865 -3	-0.3%	-$791	0.01%	279
2019 Q3	$236K	Buy	868 +18	+2%	+$5.01K	0.01%	278
2019 Q2	$234K	Sell	850 -4,174	-83%	-$1.03M	0.01%	264
2019 Q1	$1.12M	Buy	+5,024	New	+$1.04M	0.05%	203

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Tiedemann Advisors's IDXX Position: Q3 2021 in Review

Tiedemann Advisors sold out of Idexx Laboratories (IDXX) in Q3 2021, closing a stake of 3,306 shares — an estimated $2.09M sold.

Tiedemann Advisors first reported a position in IDXX in Q1 2019 and held it in 6 quarters. The position peaked at $2.09M in Q2 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2021.

Tiedemann Advisors reported no remaining Idexx Laboratories position as of Q3 2021 after selling out during the quarter.
Tiedemann Advisors sold 3,306 Idexx Laboratories shares in Q3 2021, an estimated $2.09M.
Tiedemann Advisors first reported a position in Idexx Laboratories in Q1 2019 and held it in 6 quarters.
Tiedemann Advisors's Idexx Laboratories position peaked at $2.09M in Q2 2021.
1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2021.

Based on Tiedemann Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.